Actinium Pharmaceuticals, Inc (ATNM) Stock Price

ATNMStock

$1.08−39.66%52W

Market Cap$33.88M

P/E—

PEG Ratio—

Div yield—

Beta0.29

ATNM Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-10.28%

Price vs S&P 500 (4W)18.13%

VGM Score47.44

Book Value / Share (Quarterly)$0.07

P/TBV (Annual)1.76x

Revenue Growth (3Y)-55.63%

Cash Flow / Share (Quarterly)$-0.73

Price vs S&P 500 (YTD)-34.75%

Net Profit Margin (TTM)-5701.11%

EPS (TTM)$-0.75

10-Day Avg Trading Volume0.23M

EPS Excl Extra (TTM)$-0.75

EPS (Annual)$-1.09

ROI (Annual)-431.96%

Net Profit Margin (5Y Avg)-5775.48%

Cash / Share (Quarterly)$1.34

ROA (Last FY)-65.45%

Revenue Growth TTM (YoY)11.11%

EBITD / Share (TTM)$-0.82

ROE (5Y Avg)-153.37%

Operating Margin (TTM)-6324.44%

Cash Flow / Share (Annual)$-0.79

P/B Ratio13.15x

P/B Ratio (Quarterly)13.55x

Net Income / Employee (Annual)$-1,355,500

EV / Revenue (TTM)-131.31x

Net Interest Coverage (TTM)-10.19x

ROA (TTM)-43.39%

EPS Incl Extra (Annual)$-1.09

Current Ratio (Annual)6.20x

Quick Ratio (Quarterly)5.73x

3-Month Avg Trading Volume0.16M

52-Week Price Return-39.66%

Revenue / Employee (TTM)$3,600

Tangible BV / Share (Quarterly)$1.59

P/S Ratio (Annual)336.74x

Asset Turnover (Annual)0.00x

52-Week High$1.81

Operating Margin (5Y Avg)-5858.31%

EPS Excl Extra (Annual)$-1.09

CapEx CAGR (5Y)-16.29%

Tangible BV CAGR (5Y)37.21%

26-Week Price Return0.96%

Quick Ratio (Annual)6.02x

13-Week Price Return-11.02%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)5.89x

Enterprise Value$-11.82M

Asset Turnover (TTM)0.00x

Book Value / Share Growth (5Y)-40.95%

Revenue / Employee (Annual)$3,600

Pretax Margin (Annual)-37652.22%

Cash / Share (Annual)$1.54

3-Month Return Std Dev66.87%

Net Income / Employee (TTM)$-938,800

ROE (Last FY)-432.56%

Net Interest Coverage (Annual)-30.00x

EPS Basic Excl Extra (Annual)$-1.09

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.75

ROI (TTM)-218.42%

P/S Ratio (TTM)336.74x

Pretax Margin (5Y Avg)-5775.48%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$2.59

Forward P/E7.75x

Price vs S&P 500 (52W)-57.97%

Year-to-Date Return-22.79%

5-Day Price Return-2.78%

EPS Normalized (Annual)$-1.09

ROA (5Y Avg)-46.97%

Net Profit Margin (Annual)-37652.22%

Month-to-Date Return25.46%

Cash Flow / Share (TTM)$-1.89

EBITD / Share (Annual)$-1.16

Operating Margin (Annual)-40274.44%

ROI (5Y Avg)-153.21%

EPS Basic Excl Extra (TTM)$-0.75

P/TBV (Quarterly)2.69x

P/B Ratio (Annual)5.42x

Pretax Margin (TTM)-5701.11%

Book Value / Share (Annual)$0.25

Price vs S&P 500 (13W)-13.81%

Beta0.29x

P/FCF (Annual)3.66x

Revenue / Share (TTM)$0.00

ROE (TTM)-218.67%

52-Week Low$0.74

gGradeB

mGradeD

vgmGradeC

ATNM Earnings Surprise History

Q2 25-0.22est. -0.35

Q3 25-0.16est. -0.32

Q4 25-0.19est. -0.19

Q1 26-0.18est. -0.22

Q2 260.89est. -0.20

ATNM Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.09

4.00

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
ATNMActinium Pharmaceuticals, Inc	—	B	D	$1.08
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Actinium Pharmaceuticals, Inc

Actinium Pharmaceuticals develops targeted radiotherapies for hard-to-treat cancers using monoclonal antibodies to deliver radioisotopes directly to cancer cells. The company's portfolio includes Iomab-B for hematopoietic stem cell transplantation and Actimab-A, in clinical trials for acute myeloid leukemia. This platform approach addresses cancers with limited existing treatment options.